As we wrap up a year of insightful columns, let’s embark on a journey to uncover the gems of positive medical news—those beacons of hope found in promising research, innovative technologies, and enhanced treatments that await us on the horizon.
The realm of medicine and health is in a perpetual state of evolution. Reflecting on the past, we recall the challenges posed by the 1918-1920 flu pandemic and the once-looming fears surrounding polio. Fast forward to today, where we’ve overcome those threats and established preventive measures, such as staying current on vaccines.
In the recent past, COVID-19 created widespread fear and took a heavy toll on lives. But there’s a positive shift in the story now. In 2023, with the help of effective vaccines, we’ve acquired a strong defense against the once daunting virus. Even if someone catches COVID-19, the impact is much less severe.
Without further ado, let’s delve into my selection of the top five “good news” stories in health and medicine for the year 2023:
- Development of the RSV Vaccine
At this point last year, hospitals faced a shortage of pediatric beds due to the spread of a harmful virus known as RSV, causing severe illness in infants and young children lacking immunity. RSV also poses a risk to older adults, potentially leading to pneumonia if contracted.
Researchers have promptly introduced RSV vaccines similar to the swift development of COVID-19 vaccines; the FDA approved these vaccines for older adults in May. Additionally, there is a maternal RSV vaccine designed to safeguard infants even before birth, as they are highly susceptible.
Currently, only 16 percent of adults above 60 have been vaccinated. It is advisable to consult with your doctor, particularly if you are frequently around young children, to discuss the RSV vaccine.
- Gene Editing for Sickle Cell Disease
Sickle cell disease, a hereditary blood disorder, disproportionately affects African Americans compared to other populations. Ordinarily, red blood cells transport oxygen throughout the body and exhibit a round and smooth shape. However, in sickle cell disease, these cells become distorted, reducing their efficiency and leading to potential blockages in blood flow. This obstruction can result in severe pain, organ damage, and even strokes.
Recently, the FDA approved the first-ever gene-editing therapy designed to address the underlying genetic issues in humans. While this groundbreaking treatment is new and has a substantial cost, its widespread availability is not imminent. Nonetheless, this development is a source of optimism.
The utilization of gene-editing technology introduces various technological hurdles and ethical considerations. Just imagine the potential if we could eradicate a disease rather than merely addressing its symptoms. A participant in the sickle-cell clinical trial expressed, “It changed my life.”
- Drugs to Treat Obesity
The estimated annual medical expenditure on adult obesity in the United States ranges from $147 billion to nearly $210 billion, primarily allocated to addressing associated conditions like diabetes and cardiovascular disease. Despite sustained efforts over the decades, ranging from dietary guidelines to surgical interventions like bariatric surgery, obesity continues to be a prevalent issue.
This year has witnessed the emergence of a novel approach to obesity treatment that has shown promising outcomes. A drug, generically called semaglutide, emulates the actions of a hormone named GLP-1. This hormone signals the brain, conveying a sense of fullness, and also retards the digestive process. Individuals using semaglutide for type 2 diabetes observed weight loss, leading to FDA approval for various semaglutide formulations specifically designed to combat obesity.
However, there are certain drawbacks to consider: the treatment can be costly, and individuals tend to experience weight regain upon discontinuation. Nevertheless, the potential impact of curbing the escalating obesity epidemic is considerable.
- World Patient Safety Day 2023: Elevating Patient Voices
The World Health Organization (WHO) set the tone for the year with its observation of “World Patient Safety Day 2023” under the theme “Elevate the voice of patients!” The WHO emphasized that treating patients as partners in their care leads to significant gains in safety, patient satisfaction, and overall health outcomes. This recognition underscores the importance of involving patients actively in their healthcare decisions.
- Artificial Intelligence (AI) as a Supportive Tool for Patient Advocacy
One of the exciting developments in 2023 is the increasing role of artificial intelligence (AI) as a support for patient advocacy. AI applications have demonstrated the potential to streamline processes, enhance diagnostic accuracy, and improve patient communication. From virtual health assistants to predictive analytics, AI is a valuable ally in empowering patients with information and supporting doctors in decision-making.
Conclusion
As we reflect on the Patient Empowerment Chronicles of 2023, it is evident that the medical landscape is undergoing a transformative shift. Doctors are equipped with innovative tools and knowledge that empower them to deliver more personalized, efficient, and effective healthcare. The collaborative efforts of the global healthcare community, coupled with advancements in technology and medical research, are paving the way for a brighter and healthier future. As doctors embrace these developments, they stand at the forefront of a new era in medicine, where the potential to improve patient outcomes and enhance the overall healthcare experience has never been greater.
On that promising note, we wish you all the happiest holidays and the best of health in 2024!
Reference
- Patient Advocate: ‘Good news’ medical stories of 2023 [Internet]. Accessed on December 29, 2023. Health and Fitness. Available from: https://www.dailyherald.com/20231223/health-and-fitness/patient-advocate-good-news-medical-stories-of-2023/
